Overwater Ventures

Overture Life, Inc. is a biotechnology company based in New York, established in 2017, that specializes in developing robotic solutions for in vitro fertilization (IVF) applications. The company focuses on automating the IVF process through innovative medical devices and embryo testing methodologies, which enhance the efficiency and success rates of fertility treatments. By optimizing resource use and lowering costs, Overture Life aims to make IVF more accessible to a broader audience. Its technology includes automated cryopreservation and embryo testing services, enabling fertility clinics to identify viable embryos prior to implantation, thereby improving patient outcomes and supporting individuals in their journey to parenthood.

Olio Labs is a biotechnology company focused on developing combination therapeutics that leverage artificial intelligence to enhance treatment efficacy and reduce side effects. By employing automated discovery methods, the company analyzes protein interactions in the body, allowing for a more comprehensive approach to therapeutic design. Unlike traditional methods that typically target a limited number of proteins, Olio Labs' innovative strategy aims to create effective treatment solutions that consider a wider range of interacting proteins, ultimately improving patient outcomes.

Gameto is a biotechnology company focused on advancing female reproductive health through innovative therapies. Recognizing the significant lack of treatment options in this underserved area, Gameto employs cutting-edge scientific techniques to develop solutions that enhance the quality of life for women. The company utilizes cellular engineering to create a platform that produces engineered ovarian and endometrial cell lines capable of mimicking the functions of natural cells, including hormone production and response. This platform underpins a portfolio of cellular therapeutics aimed at addressing various female reproductive diseases. Gameto's first initiative, Fertilo, targets improvements in in vitro fertilization (IVF) and egg freezing processes, striving to make them shorter, safer, and more effective. Additionally, the company is developing Deovo, an organoid model of the female reproductive system, and Ameno, a cell-based therapy designed to mitigate health issues related to primary ovarian insufficiency and menopause. Through these efforts, Gameto aims to transform the landscape of female reproductive health care.

Tiny Health is a prominent microbiome health platform focused on addressing chronic health conditions and optimizing overall well-being. The company offers innovative at-home microbiome testing kits, including the Gut Health Test specifically designed for pregnant mothers and their babies, as well as tests for older children and adults and Vaginal Health Tests. By utilizing shotgun metagenomics, Tiny Health provides families with personalized insights into their gut and vaginal microbiomes, allowing them to make informed dietary and lifestyle changes. To date, approximately 30,000 families have relied on Tiny Health's expertise to correct microbiome imbalances and enhance health outcomes, with many experiencing significant symptom reduction or even reversal of chronic conditions. The team at Tiny Health comprises leading scientists and medical professionals from prestigious institutions, ensuring a strong foundation in evidence-based health solutions.

Overstory is a technology company that uses AI and advanced satellite imagery analysis to help electric utilities manage vegetation risks around their power lines. By identifying and prioritizing potential hazards before they cause outages or wildfires, Overstory enables transmission and distribution operators to optimize resources, improve operational efficiency, and enhance grid resilience.

Hyfé is a feedstock processing company focused on transforming food waste into valuable chemicals and materials, thereby promoting sustainability in various industries. By utilizing fungal fermentation, Hyfé upcycles waste generated during food manufacturing, enabling the production of cost-competitive essential goods. This innovative approach not only maximizes profits for food manufacturers but also contributes to reducing the carbon footprint of the food industry. Through its commitment to creating sustainable chemicals, materials, fuels, and foods, Hyfé aims to unlock the full value of every crop while providing alternatives to petroleum-based products.

Gameto is a biotechnology company focused on advancing female reproductive health through innovative therapies. Recognizing the significant lack of treatment options in this underserved area, Gameto employs cutting-edge scientific techniques to develop solutions that enhance the quality of life for women. The company utilizes cellular engineering to create a platform that produces engineered ovarian and endometrial cell lines capable of mimicking the functions of natural cells, including hormone production and response. This platform underpins a portfolio of cellular therapeutics aimed at addressing various female reproductive diseases. Gameto's first initiative, Fertilo, targets improvements in in vitro fertilization (IVF) and egg freezing processes, striving to make them shorter, safer, and more effective. Additionally, the company is developing Deovo, an organoid model of the female reproductive system, and Ameno, a cell-based therapy designed to mitigate health issues related to primary ovarian insufficiency and menopause. Through these efforts, Gameto aims to transform the landscape of female reproductive health care.

Overstory is a technology company that uses AI and advanced satellite imagery analysis to help electric utilities manage vegetation risks around their power lines. By identifying and prioritizing potential hazards before they cause outages or wildfires, Overstory enables transmission and distribution operators to optimize resources, improve operational efficiency, and enhance grid resilience.